tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market
Advertisement

Urogen Pharma (URGN) Technical Analysis

Compare
624 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Urogen Pharma’s (URGN) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting Urogen Pharma is a Buy.
Urogen Pharma’s (URGN) 20-Day exponential moving average is 18.49, while Urogen Pharma’s (URGN) share price is $18.34, making it a Sell.
Urogen Pharma’s (URGN) 50-Day exponential moving average is 17.83, while Urogen Pharma’s (URGN) share price is $18.34, making it a Buy.

Urogen Pharma (URGN) Pivot Points

Sep 29, 2025, 09:32 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.94
16.49
16.88
17.43
17.82
18.37
18.76
Fibonacci
16.49
16.85
17.07
17.43
17.79
18.01
18.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (URGN) Moving Averages

Sep 29, 2025, 09:32 PM
Period
Simple
Exponential
MA5
17.89Buy
17.98Buy
MA10
18.05Buy
18.19Buy
MA20
18.79Sell
18.49Sell
MA50
18.85Sell
17.83Buy
MA100
14.54Buy
15.96Buy
MA200
12.61Buy
14.05Buy
Urogen Pharma’s (URGN) 10-Day exponential moving average is 18.19, while Urogen Pharma’s (URGN) share price is $18.34, making it a Buy.
Urogen Pharma’s (URGN) 100-Day exponential moving average is 15.96, while Urogen Pharma’s (URGN) share price is $18.34, making it a Buy.
Urogen Pharma’s (URGN) stock price is $18.34 and Urogen Pharma’s (URGN) 50-day simple moving average is 18.85, creating a Sell signal.
Urogen Pharma’s (URGN) stock price is $18.34 and Urogen Pharma’s (URGN) 100-day simple moving average is 14.54, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $18.34 and Urogen Pharma’s (URGN) 200-day simple moving average is 12.61, creating a Buy signal.

Urogen Pharma (URGN) Technical Indicators

Sep 29, 2025, 09:32 PM
Name
Value
Implied Action
RSI (14)
48.83
Neutral
STOCH (9,6)
34.56
Neutral
STOCHRSI (14)
13.86
Buy
MACD (12,26)
-0.24
Buy
ADX (14)
16.93
Buy
Williams %R
-72.20
Buy
CCI (14)
-79.62
Neutral
ATR (14)
1.02
-
Ultimate Oscillator
45.37
Neutral
ROC
-14.38
Sell
Urogen Pharma’s (URGN) Relative Strength Index (RSI) is 48.83, creating a Neutral signal.
Urogen Pharma’s (URGN) Trend Strength Indicator (ADX) is 16.93, creating a Buy signal.
Urogen Pharma’s (URGN) Commodity Channel Index (CCI) is -79.62, creating a Neutral signal.
Urogen Pharma’s (URGN) Price Rate of Change (ROC) is -14.38, creating a Sell signal.

FAQ

Is URGN a Buy, Hold, or Sell?
Based on URGN’s technical indicators, URGN is a Buy.
    What is URGN’s RSI (14)?
    URGN’s RSI (14) is 48.83, which suggests URGN is a Neutral.
      What is URGN’s MACD?
      URGN’s MACD is -0.24, which suggests URGN is a Buy.
        What is URGN’s 5-day moving average?
        URGN’s 5-day moving average is 17.89, which suggests URGN is a Buy.
          What is URGN’s 20-day moving average?
          URGN 20-day moving average is 18.79, which suggests URGN is a Sell.
            What is URGN’s 50-day moving average?
            URGN’s 50-day moving average is 18.85, which suggests URGN is a Sell.
              What is URGN’s 200-day moving average?
              URGN’s 200-day moving average is 12.61, which suggests URGN is a Buy.
                What is URGN’s Williams % R (14)?
                URGN’s Williams % R (14) is -72.20, which suggests URGN is a Buy.
                  What is URGN’s CCI (14)?
                  URGN’s CCI (14) is -79.62, which suggests URGN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis